Nanoparticles and antigen-specific T-cell therapeutics: a comprehensive study on uptake and release
T lymphocytes are used as cellular therapeutics in many disease entities including cancer. We investigated the uptake and retention of nanoparticles (NPs) by these nonphagocytic cells. Uptake, release and toxicity of various polymeric NP preparations were analyzed by flow cytometry, confocal laser s...
Saved in:
Published in | Nanomedicine (London, England) Vol. 10; no. 7; pp. 1063 - 1076 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Future Medicine Ltd
01.04.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | T lymphocytes are used as cellular therapeutics in many disease entities including cancer. We investigated the uptake and retention of nanoparticles (NPs) by these nonphagocytic cells.
Uptake, release and toxicity of various polymeric NP preparations were analyzed by flow cytometry, confocal laser scanning microscopy and transmission electron microscopy. T-cell effector functions were measured using IFN-γ-ELISPOT and
Chromium-release assays.
Amino-functionalized NPs were efficiently ingested by antigen-specific T cells without adversely influencing effector functions. NPs were stored in membrane-surrounded vesicles, with major proportions released extracellularly during 24 h.
Amino-functionalized polymeric NPs are efficiently taken up by human T cells and could be used to design nanocarriers for direct access and manipulation of antigen-specific T cells
. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1743-5889 1748-6963 |
DOI: | 10.2217/nnm.14.160 |